NasdaqGS - Nasdaq Real Time Price USD
Precigen, Inc. (PGEN)
As of 2:38 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AGEE NANCY HOWELL Director | Stock Award(Grant) | Jul 5, 2024 | 17,605 |
| FRANK STEVEN R Director | Stock Award(Grant) | Mar 14, 2024 | 1,024,160 |
| KIRK RANDAL JOE Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 9, 2024 | -- |
| LEHR DONALD P Officer | Conversion of Exercise of derivative security | Apr 5, 2024 | 538,126 |
| MITCHELL DEAN J Director | Stock Award(Grant) | Mar 14, 2024 | 503,183 |
| PEREZ JEFFREY THOMAS Officer | Purchase | Aug 9, 2024 | 743,097 |
| SABZEVARI HELEN Chief Executive Officer | Conversion of Exercise of derivative security | Apr 5, 2024 | 2,221,080 |
| SHAH RUTUL R. Chief Operating Officer | Conversion of Exercise of derivative security | Apr 5, 2024 | 209,746 |
| THOMASIAN HARRY JR. Chief Financial Officer | Conversion of Exercise of derivative security | Apr 5, 2024 | 229,376 |
| TURLEY JAMES S Director | Stock Award(Grant) | Mar 14, 2024 | 472,441 |
Related Tickers
TCRT Alaunos Therapeutics, Inc.
2.0800
+2.97%
MRSN Mersana Therapeutics, Inc.
2.5300
+8.12%
VOR Vor Biopharma Inc.
0.8330
-3.14%
CRMD CorMedix Inc.
10.59
+2.61%
MCRB Seres Therapeutics, Inc.
0.7252
-3.97%
LYEL Lyell Immunopharma, Inc.
1.2050
-18.58%
CDXS Codexis, Inc.
4.1750
+4.11%
OMGA Omega Therapeutics, Inc.
1.1100
-1.78%
LYRA Lyra Therapeutics, Inc.
0.2734
-2.32%
TSHA Taysha Gene Therapies, Inc.
1.4100
+2.92%